Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives

Details for Australian Patent Application No. 2009212805 (hide)

Owner Baxter Healthcare S.A. Baxter International Inc.

Inventors Oldenburg, Johannes; Fregin, Andreas; Rost, Simone; Muller-Reible, Clemens R.; Strom, Tim-Matthias

Agent Cullen & Co

Pub. Number AU-A-2009212805

Parent 2004283246

Filing date 26 August 2009

Wipo publication date 17 September 2009

International Classifications

C12N 9/04 (2006.01) Enzymes, e.g. ligases (6.) - acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)

Event Publications

10 September 2009 Complete Application Filed

17 September 2009 Application Open to Public Inspection

  Published as AU-A-2009212805

17 September 2009 Corrigenda

  Complete Applications Filed - Name Index Under the name Baxter Healthcare S.A.; Baxter International Inc., Application No. 2009212805, under INID (54) correct the title to read Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009212806-Anthracycline-antibody conjugates

2009212804-Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use